Somerset Lung Centre, Taunton and Somerset NHS Foundation Trust.
Clin Med (Lond). 2011 Jun;11(3):275-8. doi: 10.7861/clinmedicine.11-3-275.
Management of SAS and cardiovascular disease risk should be closely linked. It is important to screen for cardiovascular disease risk in patients with SAS and vice versa. CSA/CSR may be improved by ventilation strategies in heart failure, but benefit remains to be proven. For OSA, although CPAP may reduce cardiovascular disease risk, its main benefit is symptom control. In the longer-term, CPAP should be used alongside standard cardiovascular risk reduction strategies including robust weight management programmes, with referral for bariatric surgery in appropriate cases. CPAP and NIV should be considered for acute admissions with decompensated cardiac failure.
SAS 的管理应与心血管疾病风险密切相关。在 SAS 患者中筛查心血管疾病风险,反之亦然,这一点很重要。心力衰竭的通气策略可能会改善 CSA/CSR,但获益仍有待证实。对于 OSA,尽管 CPAP 可能降低心血管疾病风险,但它的主要益处是控制症状。在长期,CPAP 应与标准的心血管风险降低策略一起使用,包括强有力的体重管理计划,并在适当情况下转介进行减重手术。对于失代偿性心力衰竭的急性入院患者,应考虑使用 CPAP 和 NIV。